Möchten Sie immer auf dem neuesten Stand bleiben?

BELTSVILLE, Md., March 31, 2026 (GLOBE NEWSWIRE) -- NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class, and...

ATLANTA, March 31, 2026 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a leading biomedical innovator making fertility and non-surgical permanent birth control more accessible and cost-effective...

ZYCUBO® approved by FDA to treat Menkes disease in the United States; Fortress subsidiary Cyprium Therapeutics sold its Rare Pediatric Disease Priority Review Voucher (PRV) for gross proceeds of $205...

Full-Year 2025 revenue of $102.4 million, a 77.3% increase over the prior-year period  Company Continues to Drive Meaningful Cost Reductions Company Issues Full Year 2026 Financial Guidance ...

Rinzimetostat 400 mg once daily selected as RP3D in combination with darolutamide for Himalayas-1 global Phase 3 registrational trial in post-abiraterone mCRPC, with initiation expected in 1H 2026 At...

DENVER, March 31, 2026 (GLOBE NEWSWIRE) -- authID® (Nasdaq: AUID) (“authID” or the “Company”), a leading provider of biometric identity verification and authentication solutions, today reported...

FREDERICK, Md., March 31, 2026 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc. (NASDAQ: TOMZ), a global provider of disinfection and decontamination essentials through its premier Binary...

Sets Revenue Records in Fourth Quarter and Full Year 2025, with Revenue of $5.4 million and $14.2 million, Respectively Provides First Quarter 2026 Revenue Guidance of $5.0 to $5.2 million...

The Novera QPU will be at the core of the University of Saskatchewan’s first quantum computing system.

Geneva, Switzerland, March 31, 2026 (GLOBE NEWSWIRE) -- Conference Call to be Held on April 1 at 9:00am ET Audited FY 2025 revenue of $18 million, representing 66% growth year-over-yearEntered...